Variation in performance in low-volume mammography screening programmes: experience from Switzerland. by Bulliard, Jean-Luc et al.
Bulliard JL, Ducros C, Dayer E, Arzel B, Levi F. Variation in performance in low-volume mammography 
screening programmes: experience from Switzerland. Cancer Epidemiol. 2011;35(3):293-7. 
 
 
Postprint Version  Final draft post-refereeing 
Journal website  http://www.sciencedirect.com/science/journal/18777821 
Pubmed link  http://www.ncbi.nlm.nih.gov/pubmed/20729158 
DOI  10.1016/j.canep.2010.07.015  
 
 
 
 
Variation in performance in low-volume mammography screening 
programmes: Experience from Switzerland 
 
J-L. Bulliard
a*
, C. Ducros
b
, E. Dayer
c
, B. Arzel
d
, F. Levi
a,e
 
a Unité d'épidémiologie du cancer, Institut de médecine sociale et préventive, Centre Hospitalier 
Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland 
b Fondation pour le dépistage du cancer du sein, Lausanne, Switzerland  
c Centre valaisan de dépistage du cancer du sein, Sion, Switzerland 
d Fondation genevoise pour le dépistage du cancer du sein, Geneva, Switzerland 
e Registre Vaudois et Neuchâtelois des Tumeurs, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, 
Lausanne, Switzerland
 
11 June 2010 
*Correspondence to : 
Unité d'épidémiologie du cancer, 
Institut de médecine sociale et préventive, 
Centre Hospitalier Universitaire Vaudois et Université de Lausanne, 
Route de la Corniche 2, 
Bâtiment Biopôle 1 
1066 Epalinges, 
Switzerland 
Fax : +41-21-314 7373 
E-mail: Jean-Luc.Bulliard@chuv.ch 
  
Bulliard JL, Ducros C, Dayer E, Arzel B, Levi F. Variation in performance in low-volume mammography 
screening programmes: experience from Switzerland. Cancer Epidemiol. 2011;35(3):293-7. 
 
 
 
Summary 
Background: Reading volume and mammography screening performance appear positively correlated. 
Quality and effectiveness were compared across low-volume screening programmes targeting 
relatively small populations and operating under the same decentralised healthcare system. Except for 
accreditation of 2nd readers (restrictive vs non-restrictive strategy), these organised programmes had 
similar screening regimen/procedures and duration, which maximises comparability. Variation in 
performance and its determinants were explored in order to improve mammography practice and 
optimise screening performance.  
Methods: Circa 200,000 screens performed between 1999 and 2006 (4 rounds) in 3 longest standing 
Swiss cantonal programmes (of Vaud, Geneva and Valais) were assessed. Indicators of quality and 
effectiveness were assessed according to European standards. Interval cancers were identified through 
linkage with cancer registries records. 
Results: Swiss programmes met most European standards of performance with a substantial, 
favourable cancer stage shift. Up to a two-fold variation occurred for several performance indicators. 
In subsequent rounds, compared with programmes (Vaud and Geneva) that applied a restrictive 
selection strategy for 2nd readers, proportions of in situ lesions and of small cancers (≤ 1cm) were one 
third lower and halved, respectively, and the proportion of advanced lesions (stage II+) nearly 50% 
higher in the programme without a restrictive selection strategy. Discrepancy in second-year 
proportional incidence of interval cancers appears to be multicausal.  
Conclusion: Differences in performance could partly be explained by a selective strategy for second 
readers and a prior experience in service screening, but not by the levels of opportunistic screening and 
programme attendance. This study provides clues for enhancing mammography screening 
performance in low-volume programmes. 
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1. Introduction 
Most western countries have established national or regional breast cancer screening programmes 
since randomised controlled trials demonstrated that mammography screening was effective in 
reducing breast cancer mortality in females aged 50 and over [1, 2]. In Switzerland, where healthcare 
delivery is organised at a regional (cantonal) level, the first screening programmes were implemented 
in 1999, following a successful pilot project [3, 4]. The development of organised programmes 
concomitantly to pre-existing opportunistic screening was facilitated by the decision of the Federal 
Office of Social Insurance to reimburse from 1999 biennial mammography screening for women aged 
50 and above through the Swiss compulsory health insurance coverage system, when performed 
within a quality-assured programme. 
 
Wide variation in performance indicators has been documented across service screening programmes 
in Europe and similar variation is expected in the impact of screening on breast cancer mortality [2]. 
This discrepancy has broadly been ascribed to differences in screening organisation and procedures, 
and to individual programme size and volume of activity [5, 6]. Most comparisons of short-term 
performance indicators have additionally been subjected to potential age confounding since screening 
performance is also sensitive to programme duration and the age groups screened [1, 7]. 
 
The region-oriented healthcare system in Switzerland enables to compare performance indicators 
across programmes initiated at the same time, with similar screening organisation and procedures, but 
with substantial differences in multiple reading strategy, population size, historical screening habits 
and prevalence of opportunistic screening [3, 4]. The aim of this study was (1) to examine the 
variation in quality and effectiveness of mammography screening in low-volume Swiss regional 
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programmes after 8 years of operation (4 screening rounds), and (2) to explore determinants of this 
variation in order to improve mammography practice and optimise screening performance.  
 
2. Materials and methods 
2.1. Organised mammography screening in Switzerland: current state 
Five mammography screening programmes are operating in Switzerland, covering six (all French-
speaking) cantons and about 25% of the Swiss female resident population aged 50-69 (Fig. 1). A sixth 
programme will start in 2010 in German-speaking Switzerland. All programmes share the same 
operating software and quality control procedures, and have joint educational material and similar 
screening procedures that include biennial double reading with arbitration and two-view 
mammography. The invitation and reading processes in Swiss programmes have been described 
elsewhere [3].  
 
This study focussed on the three longest standing programmes (Vaud (VD), Geneva (GE) and Valais 
(VS)) which all were launched in 1999 (Fig. 1). Programmes in the cantons of Fribourg (FR-2004) and 
Jura/Neuchâtel (JU-2005/ NE-2007) were too recent to have reached their full potential. The three 
programmes considered took place in cantons with different population characteristics with respect to 
breast cancer screening, but with similar age structure of their 50-69 female populations. 
 
2.2. The Vaud screening programme 
The pioneer activities in breast cancer screening in the Vaud canton contributed to the development of 
service screening programmes in Switzerland [3]. This largest Swiss programme – it encompassed 
over 40% of all programme-based mammograms – elicited stringent criteria for second reader 
radiologists in order to comply with the 5000 minimum reading requirement recommended in the 
European guidelines (Table 1) [8]. Several accredited radiologists had prior experience with 
mammography reading in an organised setting from the pilot trial [3]. Exposure to organised screening 
from the pilot programme, but not accessibility, influenced participation in this canton [9]. In this 
region with a dense offer of screening facilities, overall attendance was about 50% but varied locally: 
the denser the population, the lower was participation [9]. 
 
2.3. The Geneva screening programme 
The Geneva programme applied a similar second reader strategy to that in Vaud. Difficulties in 
collaborating with private radiologists temporarily hindered the development of a programme 
(participation rate: about 25%) set in a population with one of the highest incidence of breast cancer 
worldwide [10]. Opportunistic screening prevails in this highly urbanised canton and has increased 
since the inception of the programme. Conflicting evidence has been reported about attraction by the 
programme of women from predominantly lower socioeconomic classes [11, 12]. 
 
2.4. The Valais screening programme 
In Valais, the second reading approach favoured volunteering, self-motivation and self-responsibility 
of radiologists. This led to more second readers with lesser annual throughput. Participation has been 
the highest among Swiss service screening programmes, almost reaching the European 
recommendation (66% vs 70%) [13]. Participation however differed within this alpine canton, being 
higher in the French than the German-speaking community [13]. 
 
2.5. Opportunistic screening 
Self-reported biennial mammography (screening and diagnostic) coverage was in 2002 about 90% in 
the 3 cantons, above the Swiss average for 50-69 year olds females (71.5%) [12]. The wide difference 
in participation across programmes (GE: 26%, VD: 49%, VS: 66%) [14] reflected different 
prevalences of opportunistic screening [4]. 
 
2.6. Analyses 
Analyses included 197,608 screens performed during the first 8 years (1999-2006) of operation among 
50-69-year-old women residing in these 3 cantons. Performance and prognostic indicators as defined 
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in the European Guidelines were calculated for prevalent (initial) and incident (subsequent) screening 
rounds for each programme [8]. Interval cancers were identified by linkage between screening and 
cancer registries records, performed separately for the Vaud, Geneva and Valais Cancer Registries. To 
estimate the proportional incidence of interval cancers (the ratio of observed to expected incidence in 
the absence of screening), age-specific breast cancer incidence rates for females aged 50-69 in the 5-
year period preceding the screening programmes were used. 
 
3. Results 
The volume of activity for each regional programme is described in Table 1. The average throughput 
ranged between circa 5000 and 13,600 yearly readings between 1999 and 2006. Both the overall and 
individual volume increased over time as participation raised (data not shown). The number of 
accredited second readers was inversely related to the population size of the programme. The 
combined effect of different participation rates and strategies for second readers led to a four-fold 
variation across programmes in the annual volume interpreted by second readers. 
 
Performance indicators for the 3 programmes, ranked by increasing size, are presented by type of 
screening round in Table 2 and the relationship between some key indicators is illustrated in Fig. 2. 
The proportion of subsequent screens ranged from 44% in GE to 57% in VD, and was 50% in VS 
(data not shown). In terms of quality, the biopsy yield and the referral rate met European standards in 
subsequent screens and, for one programme only, in initial screens. Overall, screening performance 
improved between prevalent and incident rounds (higher PPV, lower false-positive and referral rates, 
Fig. 2). This improvement was accompanied by less heterogeneity in performance across programmes 
in subsequent screens (Fig. 2).  
 
The fraction of women reinvited within 2 years was too low for the 3 programmes (65-92% vs 95% 
recommended, Table 2), although the reinvitation rate at 30-month substantially improved and reached 
the European norm for one programme. The median time between two screening invitations was 719 
days (VD), 739 days (VS) and 742 days (GE), respectively, and these delays decreased over screening 
rounds (data not shown). 
 
Most indicators of screening effectiveness fulfilled European requirements for all programmes (Table 
2). The proportion of advanced cancers was consistently high, irrespective of screening round. 
Substantial regional variations were observed for (1) in situ cancers whose rates were 50% lower in 
VS than elsewhere, (2) small cancers (≤ 1 cm) in subsequent screens whose proportion was in VS half 
that in VD and GE, and (3) interval cancers for which the second-year proportional incidence was 50% 
greater in GE (67%) than in VD (42%). 
 
4. Discussion  
Swiss mammography screening programmes met most international standards of quality and 
effectiveness [8]. Performance was in line with other European service screening programmes [2, 15]. 
However, up to a two-fold variation was observed in interim indicators of performance across these 
programmes despite the same screening regimen (double reading with arbitration, two-view biennial 
mammography, same length of operation) and common physical/technical quality control of 
radiological equipment. 
 
The goal of any cancer screening initiative is to obtain a high cancer detection rate while minimising 
interval cancer and avoiding unnecessary diagnostic evaluation following false-positive results, which 
are costly and associated with psychological morbidity [1]. Consequently, a programme with a low 
referral rate and high interval cancer rate (high specificity/low sensitivity), like in The Netherlands 
[16], or a high referral rate and low interval cancer rate may reflect two screening policies or strategies 
with similar overall performance. 
 
Screening policy and criteria are uniform in Swiss programmes [4] and indicators of programmes’ 
sensitivity and specificity were weakly related (Fig. 2). For instance, one programme (VD) had in the 
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initial round the lowest referral and false-positive rates, the lowest 2-year interval cancer rate 
(1.9/1000 versus 2.3/1000 (VS) and 2.5/1000 (GE)) but the highest detection rate. Regional variations 
in cancer detection appear unlikely to be due to differential background risk since pre-screening levels 
of incidence differ by less than 5% in these regions (ranging from 290 to 303 per 100,000 for women 
aged 50-69) and self-selection of participants seems to occur on common factors across Swiss 
programmes (Swiss nationality, married and younger women) [17, 18]. 
 
Although random fluctuations cannot be discarded, our results are compatible with a genuine 
difference in performance across Swiss programmes, at least in initial round. Higher performance was 
observed in the region (VD) that had both a prior pilot trial [3] and the highest annual volume per 
second reader. Our results show that expertise has successfully been transferred from an experimental 
setting to a service programme and confirm that quality improved in service programmes with 
duration of activity [7]. 
 
Performance indicators were closer for the two programmes (VD and GE) that elicited a restrictive 
second reading strategy. In Switzerland, accredited radiologists interpret screening mammograms both 
within and outside the setting of a service programme. Although the total annual throughput of 
radiologists was unknown, those reading less mammograms within a programme were likely to 
interpret more mammograms outside a programme as overall screening coverage and number of 
radiologists per capita were roughly comparable in the three regions [12]. These results confirm that 
performance per se is independent from the level of attendance [19]. In presence of substantial, 
concomitant opportunistic screening, the relationship between volume and accuracy remains difficult 
to measure in screening programmes. 
 
Comparisons are generally more reliable for subsequent rounds since differences in women’s prior 
screening practices (i.e. opportunistic screening) are largely attenuated after an initial round. 
Performance appears to vary mostly in subsequent rounds between the regional programme (VS) that 
favoured self-motivation and self-responsibility of radiologists to perform second readings and those 
programmes (VD and GE) that elicited a selective strategy for accreditating 2nd readers. The VS 
programme showed the highest participation but the lowest detection rate, with both fewer small 
cancers (<1cm or in situ) and more advanced lesions being detected for rather similar proportional 
incidence of interval cancers as GE and VD. A restrictive accreditation of second readers led to a 
median throughput four times higher for second than first readers. Despite this measure, no Swiss 
programme reached the reading threshold of 5000 cases per year for second readers. Such a threshold 
has rarely been met in low-volume screening programmes run in decentralised healthcare systems 
[20]. To our knowledge, there is no specific recommendation aimed at optimising accuracy of 
mammography interpretation for low-volume screening programmes. Strong restriction on second 
readers’ accreditation and/or a centralisation of breast assessment in liberal healthcare system can 
improve performance in low-volume programmes [21]. 
 
Even though indicators of early effectiveness (% of cancers in situ, ≤ 1cm, N0) met the criteria of the 
European community, the proportion of screen-detected cancers of stage II+ was consistently higher 
than the reference value [8]. Similar proportions of advanced cancers have been observed in two high-
quality Scandinavian service programmes, and a revision of the European criterion for the stage 
distribution has been proposed [22, 23]. A trend analysis of advanced breast cancer rates by detection 
mode in these Swiss populations is warranted prior to any speculative interpretation. 
 
The relative incidence of first-year but not second-year interval cancer met the levels set by the 
European guidelines [8]. Similar findings were reported in a pooled analysis of interval cancers in six 
European countries, as well as in Norway [15, 24]. Apart from random variability due to few numbers 
in our series, an update of the current guidelines (based on the Swedish Two-County trial) has been 
suggested since they do not consider changes in background incidence unrelated to the screening 
programme [22]. A high completeness of cancer registration, an accurate linkage procedure to identify 
interval cancers and a substantial prevalence of concomitant opportunistic screening have been 
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evidenced to contribute to a greater frequency of interval cancer, regardless of screening quality [25]. 
All these factors apply to Switzerland. 
 
A temporal bias has been advanced to explain the sharp increase between first and second-year 
proportional incidence [26]. The date of incidence mostly recorded by cancer registries is the date of 
the first positive histology report or hospital admission, and not that of the onset of symptoms. This 
shift in time of diagnosis led some first-year interval cancers to appear as second-year cancers in non-
research setting. 
 
To our knowledge, evaluation of timeliness in screening programmes has not been documented in the 
scientific literature. No Swiss programme reinvited 95% of screen-eligible women within 24 months, 
as recommended in the European guidelines [8]. Invitation letters do not specify a time or place in 
Switzerland and subsequent invitations are automatically sent 22-month after the prior screening test. 
Waiting time for a screening appointment in a radiology centre is a major contributor to this delay [9]. 
Delays do not affect screening performance per se but, if too lengthy, may incite women to be 
screened outside the programme and decrease attendance. 
 
In conclusion, variation of performance across Swiss service programmes was related to difference in 
multiple reading strategies and a prior experience in service screening, but could not be explained by 
levels of opportunistic screening and programme attendance. The lesser second readers, the higher the 
screening performance. Performance improved over time in all programmes but variability in process 
indicators subsisted between programmes with and without a selective 2nd readers strategy. 
Centralisation of second readings to fewer radiologists should further improve mammography practice 
and screening performance in low-volume programmes. 
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Table 1: Screening activity in the 3 main Swiss regional programmes, 1999-2006 
Parameter GE VS VD 
Target population invited, 50-69 years old 
womena 
72,655 44,237 100,853 
Mean annual  number of mammography 5069 8242 13,598 
Number of accredited radiology centres 11 
 
11 29 
Mean annual number of accredited 
radiologists 
27 
 
22 34 
Mean annual number of 2nd readers 6 
 
11 4 
Annual volume (all readers) 
 Mean 
 Median 
 
188 
194 
 
746 
646 
 
364 
852 
 Annual volume (2nd readers only) 
  Mean 
 Median 
 
813 
758 
 
1086 
939 
 
3390 
3334 
GE : Geneva VS: Valais VD: Vaud 
a Includes ineligible women  
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Table 2: Indicators of screening performance (quality, timeliness and effectiveness) in Swiss 
regional  programmes, 1999-2006 
Performance indicator GE 
n=40,553 
VS  
n=52,889 
 
VD 
n=104,166 
European norms 
Referral rate (%) 
 Initial screen 
 Subsequent screen 
 
 8.0 
 4.7 
 
 7.1 
 3.3  
 
6.4 
3.9 
 
< 7 
< 5 
Benign to malignant biopsy ratio 
 Initial screen 
 Subsequent screen 
 
 n.a 
 n.a 
 
 0.55 
 0.24  
 
0.47 
0.28 
 
 ≤ 0.5 
 ≤ 0.25 
Timeliness (%) 
 Re-invitation within 24 months 
 Re-invitation within 30 months 
 
 65.0 
 92.0 
 
 83.2  
 94.6 
 
91.8 
98.0 
 
> 95 
> 98 
Detection rate (/1,000) 
 Initial screen 
 Subsequent screen 
 
 6.5 
 6.2 
 
 6.2 
 4.8  
 
7.6 
5.9 
 
 (3xI.R) 
 (1.5xI.R) 
In situ cancers (%) 
 Initial screen 
 Subsequent screen 
 
 18.9 
 18.9 
 
 12.2 
 12.5  
 
18.2 
17.1 
 
10-20 
10-20 
Invasive cancers ≤ 10mm (%) 
 Initial screen 
 Subsequent screen 
 
 27.5 
 40.2 
 
 25.2 
 21.2  
 
39.6 
44.7 
 
≥ 25 
≥ 25 
Stage II+ (%) 
 Initial screen 
 Subsequent screen 
 
 31.5 
 29.6 
 
 35.4 
 39.3 
 
29.7 
28.9 
 
< 30 
≤ 25 
Node-negative cancers (%) 
 Initial screen 
 Subsequent screen 
 
 75.4 
 74.7 
 
 74.3 
 75.9 
 
72.3 
73.8 
 
≥ 70 
≥ 75 
Interval cancers (initial screen, 
proportional incidence) 
 0-11 months after screening 
 12-23 months after screening 
 n=56 
 
 15.0 
 67.0 
 n=59 
 
 27.3 
 53.2 
n=77 
 
24.0 
41.9 
 
 
≤ 30 
≤ 50 
GE : Geneva VS: Valais VD: Vaud  n.a.: not available I.R: incidence rate 
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Fig. 1: Organised breast cancer screening programmes in Switzerland, 2010 
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Fig. 2: Performance of mammography screening programmes in Switzerland, (a) detection rate vs 
false-positive rate, (b) positive predictive value vs referral rate, by type of screening round 
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